Study collects tissue samples and tracks neuroendocrine tumors
Part of Cancer clinical trials.
This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 years or older.
- You can understand the study and are willing to sign written consent.
- You have a confirmed diagnosis of a neuroendocrine tumor (or adrenocortical cancer) by biopsy/cell testing, OR strong lab test signs, OR imaging that suggests it, OR a genetic risk for these tumors.
- If you don’t already have biopsy confirmation, your diagnosis may be based on abnormal blood/urine hormone or tumor marker tests.
- If your diagnosis is still “suspected,” your CT/MRI/PET/68Ga-Dotatate scan must suggest a neuroendocrine tumor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether specific blood “biomarkers” can help confirm a type of cancer called NEN (neuroendocrine neoplasm) and show whether treatment is working early. It may help doctors start or adjust treatment sooner, especially for cancers that are advanced or have spread.
This study looks at pituitary gland tumors (called Pit-NETs) using stored tumor samples and long-term follow-up information. It aims to learn more about how these tumors behave, which might help doctors treat them better in the future.
This study looks at how tumor and patient factors affect treatment response in well-differentiated GEP-NENs (neuroendocrine tumors of the digestive system). It may help doctors understand which treatments work best for people like you.
This study collects and analyzes molecular (cell/DNA-level) information from endocrine tumors or pre-cancer conditions. It may help doctors better understand these tumors and improve diagnosis and treatment planning when you need surgery or a biopsy.
This study collects tumor (or related) samples to analyze their genes and build a shared research “biobank.” It may help researchers understand cancers better for future diagnosis and treatments.
This study keeps a worldwide record of people with neuroendocrine tumors to learn about care patterns and outcomes. It may help your doctors and future patients by improving how these tumors are monitored and treated.
Hear when a new Neuroendocrine Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.